Yang et al. [19] found that EPO administration promoted the growth of pituitary adenomas by enhancing angiogenesis via the EPO–JAK-2–STAT-3–VEGF (Figure 1) signaling pathway and should be used with caution in anemia patients bearing pituitary adenoma due to its potentially deleterious effects. Here, EPO is linked to anemia.